We are live on ! Find out more
RPAM

Rhenman & Partners Asset Management Portfolio holdings

AUM $810M
1-Year Est. Return 30.2%
This Fund
S&P 500
This Quarter Est. Return
-13.46%
1 Year Est. Return
+30.2%
3 Year Est. Return
+116.38%
5 Year Est. Return
+153.13%
10 Year Est. Return
+962.25%
AUM
$627M
AUM Growth
-$205M
Cap. Flow
-$88.2M
Cap. Flow %
-14.06%
Top 10 Hldgs %
25.67%
Holding
102
New
6
Increased
38
Reduced
34
Closed
11

Top Buys

Rank Stock Value
1
CI icon
Cigna
CI
+$15.4M
2
HUM icon
Humana
HUM
+$14.8M
3
PFE icon
Pfizer
PFE
+$14.2M
4
MCK icon
McKesson
MCK
+$11M
5
AMGN icon
Amgen
AMGN
+$10.4M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$20.3M
2
JNJ icon
Johnson & Johnson
JNJ
+$18.6M
3
UNH icon
UnitedHealth
UNH
+$10.1M
4
RAD
Rite Aid Corporation
RAD
+$9.6M
5
CVS icon
CVS Health
CVS
+$9.15M

Sector Composition

Rank Sector Weight
1 Healthcare 91.99%
2 Financials 2.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMGN icon
1
Amgen
AMGN
$208B
$18.7M 2.98%
135,000
+66,000
+96% +$10.4M
ALXN
2
DELISTED
Alexion Pharmaceuticals
ALXN
$18M 2.87%
115,000
-17,800
-13% -$3.25M
MDT icon
3
Medtronic
MDT
$109B
$17.7M 2.83%
265,000
+110,200
+71% +$8.12M
UNH icon
4
UnitedHealth
UNH
$376B
$17.1M 2.72%
147,000
-84,000
-36% -$10.1M
LLY icon
5
Eli Lilly
LLY
$1.02T
$15.5M 2.47%
185,000
+10,000
+6% +$844K
AET
6
DELISTED
Aetna Inc
AET
$15.1M 2.41%
138,000
+87,000
+171% +$10.1M
ELV icon
7
Elevance Health
ELV
$81.5B
$15M 2.39%
107,000
+49,000
+84% +$7.36M
ALKS icon
8
Alkermes
ALKS
$8.22B
$15M 2.39%
255,000
-94,000
-27% -$6.21M
CELG
9
DELISTED
Celgene Corp
CELG
$14.7M 2.35%
136,000
-1,000
-0.7% -$124K
HUM icon
10
Humana
HUM
$43.7B
$14.3M 2.28%
+80,000
New +$14.8M
CI icon
11
Cigna
CI
$73.7B
$14.3M 2.28%
+105,900
New +$15.4M
MCK icon
12
McKesson
MCK
$100B
$14.2M 2.27%
77,000
+52,000
+208% +$11M
HCA icon
13
HCA Healthcare
HCA
$87.2B
$13.9M 2.22%
180,000
+111,000
+161% +$9.83M
PFE icon
14
Pfizer
PFE
$143B
$13.2M 2.11%
+443,734
New +$14.2M
AGN
15
DELISTED
Allergan plc
AGN
$12.5M 1.99%
46,000
+4,000
+10% +$1.23M
CAH icon
16
Cardinal Health
CAH
$53.9B
$12.2M 1.95%
159,000
-56,000
-26% -$4.68M
BDX icon
17
Becton Dickinson
BDX
$45.6B
$12.1M 1.92%
93,275
+31,775
+52% +$4.44M
INCY icon
18
Incyte
INCY
$24.2B
$12M 1.92%
109,000
+1,498
+1% +$168K
STJ
19
DELISTED
St Jude Medical
STJ
$12M 1.91%
190,000
+107,000
+129% +$7.64M
ABBV icon
20
AbbVie
ABBV
$443B
$11.4M 1.82%
210,000
-23,000
-10% -$1.5M
BMY icon
21
Bristol-Myers Squibb
BMY
$133B
$11.4M 1.81%
192,000
-6,000
-3% -$381K
GILD icon
22
Gilead Sciences
GILD
$162B
$11.3M 1.8%
115,000
-15,000
-12% -$1.67M
VRTX icon
23
Vertex Pharmaceuticals
VRTX
$121B
$10.9M 1.74%
105,000
+50,000
+91% +$6.42M
PRGO icon
24
Perrigo
PRGO
$1.4B
$10.2M 1.63%
65,000
+18,000
+38% +$3.3M
CNC icon
25
Centene
CNC
$30.7B
$9.49M 1.51%
350,000
+242,000
+224% +$8.1M
1
2 3 4 5

Similar funds

BBI
Baxter Bros Inc Riverside, Connecticut $810M AUM 16.24% 1-Year Est. Return
SSG
Summit Securities Group New York $810M AUM 27.35% 1-Year Est. Return
PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
ACM
Ashford Capital Management Wilmington, Delaware $809M AUM 35.1% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
DWA
Dorsey Wright & Associates Pasadena, California $807M AUM 65.46% 1-Year Est. Return
SLG
Stanley-Laman Group Berwyn, Pennsylvania $814M AUM 40.24% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return

Rhenman & Partners Asset Management's Q3 2015 Portfolio in Review

As of Q3 2015, Rhenman & Partners Asset Management held 102 positions worth $627M, down 25% from $833M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Rhenman & Partners Asset Management withdrew a net $88.2M in Q3 2015, closing 11 positions and reducing 34 holdings. Its most notable exit was Biogen, an estimated $20.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 92% of assets, up from 77% a quarter earlier, followed by Financials.

Against the trend, Rhenman & Partners Asset Management opened a new position in Cigna worth $14.3M.

  • Rhenman & Partners Asset Management's largest Q3 2015 buy was Cigna: 105,900 shares worth $14.3M.
  • Rhenman & Partners Asset Management added most to McKesson in Q3 2015, an estimated $11M increase.
  • Rhenman & Partners Asset Management's biggest Q3 2015 reduction was UnitedHealth, cutting an estimated $10.1M.
  • Rhenman & Partners Asset Management fully exited Biogen in Q3 2015, selling an estimated $20.3M.
  • Rhenman & Partners Asset Management's ten largest holdings make up 26% of its $627M portfolio in Q3 2015.
  • Rhenman & Partners Asset Management opened 6 new positions and closed 11 in Q3 2015.
  • Rhenman & Partners Asset Management's portfolio value fell 25% quarter-over-quarter to $627M.

Based on Rhenman & Partners Asset Management's 13F filing for Q3 2015, filed 26 Oct 2015.